Who owns MARKER THERAPEUTICS INC COM NEW?
- Ticker: MRKR
- CUSIP Number: 57055l206
Tip: Access positions for across all investors
Analyze quarterly positions in Marker Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Marker Therapeutics stock
Who bought or sold MARKER THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 1.1M | $5.9M | 0% | Dec 2023 |
|
| Aisling Capital Management | 314k | $1.7M | 0% | Dec 2023 |
|
| Vanguard Group | 225k | $1.2M | 2% | Dec 2023 |
|
| Wedbush Morgan Securities | 70k | $382k | 20% | Dec 2023 |
|
| Dimensional Fund Advisors | 20k | $112k | 0% | Dec 2023 |
|
| Creative Planning | 17k | $95k | 0% | Dec 2023 |
|
| Matrix Asset Advisors | 15k | $65k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 6.4k | $35k | -39% | Dec 2023 |
|
| Bank of America Corporation | 2.3k | $13k | -28% | Dec 2023 |
|
| Riggs Asset Managment | 1.6k | $8.8k | -32% | Dec 2023 |
|
| Us Bancorp | 839.00 | $4.6k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 283.00 | $1.6k | 1% | Dec 2023 |
|
| Huntington National Bank | 70.00 | $385.000000 | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 33.00 | $181.500000 | -96% | Dec 2023 |
|
| Royal Bank of Canada | 31.00 | $0 | 0% | Dec 2023 |
|
| Versant Capital Management | 15.00 | $64.999500 | 0% | Mar 2024 |
|
Who sold out of Marker Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Sep 2023 | 93.00 | $421.996800 |